LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹38 Cr | ₹57 Cr | ₹72 Cr | ₹130 Cr | ₹162 Cr |
What is the latest Total Debt ratio of LYKA LABS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹162 Cr |
How is Total Debt of LYKA LABS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -32.99 | |
| Mar2024 | ₹57 Cr | -21.44 | |
| Mar2023 | ₹72 Cr | -44.54 | |
| Mar2022 | ₹130 Cr | -19.86 | |
| Mar2021 | ₹162 Cr | - | |
Compare Total Debt of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹338.7 Cr | 0.5% | -5% | -31.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,471.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,294.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,946.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,691.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,214.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 0.5% |
-5% |
-31.6% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses